| Primary information |
|---|
| ID | 13581 |
| Uniprot ID | Q9Y5Q6 |
| Description | Insulin-like peptide INSL5 (Insulin-like peptide 5) [Cleaved into- Insulin-like peptide INSL5 B chain; Insulin-like peptide INSL5 A chain] |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the insulin family. |
| Tissue Specificity | Highly expressed in rectum with lower levels in uterus and ascending and descending colon. |
| Post Translational Modification | NA |
| Function | May have a role in gut contractility or in thymic development and regulation. Activates RXFP4 with high potency and appears to be the endogenous ligand for this receptor. |
| Length | 135 |
| Molecular Weight | 15 |
| Name | NA |
| Sequence | NA |
| Sequence map | NA |
| PDB ID | 2K1V; 2KBC; |
| Drugpedia | NA |
| Receptor | Q8TDU9 |
| Domain | NA |
| Pharmaceutical Use | NA
|